Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: A prospective longitudinal study

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  Barbeito, Sara ^a   Vega, Patricia ^a   Ruiz de Azúa, Sonia ^a,c   Saenz, Margarita ^a   Martinez Cengotitabengoa, Mónica ^a,b   González Ortega, Itxaso ^a,c   Bermudez, Cristina ^a   Hernanz, Margarita ^a   Corres, Blanca Fernández de ^a   González Pinto, Ana ^a,c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^b UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Adherence; Cannabis; First psychotic episode; Involuntary admission

Indexed keywords

ADULT; ARTICLE; CANNABIS ADDICTION; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT OF FUNCTIONING; HAMILTON SCALE; HUMAN; INVOLUNTARY COMMITMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME VARIABLE; PATIENT COMPLIANCE; PSYCHOSIS;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA SMOKING; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS;

EID: 84888376233     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-326     Document Type: Article

References (40)

1. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002, 106:286-290. 10.1034/j.1600-0447.2002.02437.x, 12225495.
2. Lambert M, Conus P, Cotton S, Robinson J, McGorry PD, Schimmelmann BG. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. J Clin Psychopharmacol 2010, 30:565-572. 10.1097/JCP.0b013e3181f058a0, 20814327.
3. Opjordsmoen S, Friis S, Melle I, Haahr U, Johannessen JO, Larsen TK, Røssberg JI, Rund BR, Simonsen E, Vaglum P, McGlashan TH. A 2-year follow-up of involuntary admission's influence upon adherence and outcome in first-episode psychosis. Acta Psychiatr Scand 2010, 121:371-376. 10.1111/j.1600-0447.2009.01536.x, 20085554.
4. De Haan L, Van Amelsvoort T, Dingemans P, Linszen D. Risk factors for medication non-adherence in patients with first-episode schizophrenia and related disorders: a prospective five year follow-up. Pharmacopsychiatry 2007, 40:264-268. 10.1055/s-2007-992141, 18030650.
5. Hill M, Crumlish N, Whitty P, Clarke M, Browne S, Kamali M, Kinsella A, Waddington JL, Larkin C, O'Callaghan E. Nonadherence to medication four years after a first episode of psychosis and associated risk factors. Psychiatr Serv 2010, 61:189-192.
6. Robinson DG, Woerner MG, Alvir JM, Bilder RM, Hinrichsen GA, Lieberman JA. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res 2002, 57:209-219. 10.1016/S0920-9964(01)00312-7, 12223252.
7. Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F, van Os J. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand 2000, 102:203-210. 10.1034/j.1600-0447.2000.102003203.x, 11008856.
8. Weiss KA, Smith TE, Hull JW, Piper AC, Huppert JD. Predictors of risk of nonadherence in outpatients with schizophrenia and other psychiatric disorders. Schizophr Bull 2002, 28:341-349. 10.1093/oxfordjournals.schbul.a006943, 12693439.
9. Figuerido JL, Gutierrez M, Mosquera F, Lalaguna B, Gonzalez-Pinto A. Involuntary admission in first psychotic episodes: related factors. Actas Esp Psiquiatr 2000, 28:275-278.
10. Kelly BD, Clarke M, Browne S, McTigue O, Kamali M, Gervin M, Kinsella A, Lane A, Larkin C, O'Callaghan E. Clinical predictors of admission status in first episode schizophrenia. Eur Psychiatry 2004, 19:67-71. 10.1016/j.eurpsy.2003.07.009, 15051104.
11. Maharaj R, Gillies D, Andrew S, O'Brien L. Characteristics of patients referred by police to a psychiatric hospital. J Psychiatr Ment Health Nurs 2011, 18:205-212. 10.1111/j.1365-2850.2010.01653.x, 21395912.
12. Kaltiala-Heino R, Laippala P, Salokangas RK. Impact of coercion on treatment outcome. Int J Law Psychiatry 1997, 20:311-322. 10.1016/S0160-2527(97)00013-7, 9347394.
13. Ghaemi SN, Pope HG. Lack of insight in psychotic and affective disorders: a review of empirical studies. Harv Rev Psychiatry 1994, 2:22-33. 10.3109/10673229409017110, 9384876.
14. O'Donoghue B, Lyne J, Hill M, Larkin C, Feeney L, O'Callaghan E. Involuntary admission from the patient's perspective. Soc Psychiatry Psychiatr Epidemiol 2010, 45:631-638. 10.1007/s00127-009-0104-7, 19669680.
15. González-Pinto A, Vega P, Ibáñez B, Mosquera F, Barbeito S, Gutiérrez M, Ruiz de Azúa S, Ruiz I, Vieta E. Impact of cannabis and other drugs on age at onset of psychosis. J Clin Psychiatry 2008, 69:1210-1216. 10.4088/JCP.v69n0802, 18681755.
16. Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 2008, 193:357-363. 10.1192/bjp.bp.107.046375, 18978312.
17. Turkington A, Mulholland CC, Rushe TM, Anderson R, McCaul R, Barrett SL, Barr RS, Cooper SJ. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry 2009, 195:242-248. 10.1192/bjp.bp.108.057471, 19721115.
18. Miller R, Ream G, McCormack J, Gunduz-Bruce H, Sevy S, Robinson DA. Prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophr Res 2009, 113:138-144. 10.1016/j.schres.2009.04.018, 2726744, 19481424.
19. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry 2005, 187:9-20. 10.1192/bjp.187.1.9, 15994566.
20. Malla A, Norman R, Schmitz N, Manchanda R, Béchard-Evans L, Takhar J, Haricharan R. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med 2006, 36:649-658. 10.1017/S0033291706007379, 16515734.
21. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured clinical interview for DSM-IV axis I disorder - SCID-I 1997, Washington DC: American Psychiatric Press.
22. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276. 10.1093/schbul/13.2.261, 3616518.
23. Peralta V, Cuesta MJ. Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1994, 22:171-177.
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.
25. Ramos-Brieva JA, Cordero-Villafafila A. A new validation of the hamilton rating scale for depression. J Psychiatr Res 1988, 22:21-28. 10.1016/0022-3956(88)90024-6, 3397906.
26. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435. 10.1192/bjp.133.5.429, 728692.
27. Harris JG. An abbreviated form of the Phillips rating scale of premorbid adjustment in schizophrenia. J Abnorm Psychol 1975, 84:129-137.
28. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976, 3:766-771.
29. Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia: I. Characteristics of outcome. Arch Gen Psychiatry 1972, 27:739-746. 10.1001/archpsyc.1972.01750300011002, 4637891.
30. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74. 10.1097/00005650-198601000-00007, 3945130.
31. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999, 37:113-124. 10.1016/S0738-3991(98)00107-4, 14528539.
32. Cassidy CM, Rabinovitch M, Schmitz N, Joober R, Malla A. A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. J Clin Psychopharmacol 2010, 30:64-67. 10.1097/JCP.0b013e3181ca03df, 20075650.
33. Keown P, Mercer G, Scott J. Retrospective analysis of hospital episode statistics, involuntary admissions under mental health Act 1983, and number of psychiatric beds in England 1996-2006. BMJ 2008, 337:a1837. 10.1136/bmj.a1837, 10.1136/bmj.a1837, 2565753, 18845592.
34. Van der Post L, Schoevers R, Koppelmans V, Visch I, Bernardt C, Mulder N, Beekman A, de Haan L, Dekker J. The Amsterdam studies of acute psychiatry I (ASAP-I); a prospective cohort study of determinants and outcome of coercive versus voluntary treatment interventions in a metropolitan area. BMC Psychiatry 2008, 8:35. 10.1186/1471-244x-8-35, 10.1186/1471-244X-8-35, 2413231, 18479518.
35. Priebe S, Katsakou C, Amos T, Leese M, Morriss R, Rose D, Wykes T, Yeeles K. Patients' views and readmissions 1 year after involuntary hospitalisation. Br J Psychiatry 2009, 194:49-54. 10.1192/bjp.bp.108.052266, 19118325.
36. Schimmelmann BG, Conus P, Cotton S, Kupferschmid S, McGorry PD, Lambert M. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur Psychiatry 2012, 27:463-469. 10.1016/j.eurpsy.2011.03.001, 21616646.
37. Gonzalez-Pinto A, Alberich S, Barbeito S, Gutierrez M, Vega P, Ibanzez B, Haidar MK, Vieta E, Arango C. Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull 2011, 37:631-639. 10.1093/schbul/sbp126, 3080669, 19915168.
38. Conus P, Lambert M, Cotton S, Bonsack C, McGorry PD, Schimmelman BG. Rate and predictors of service disengagement in an epidemiological first-episode psychosis cohort. Schizophr Res 2010, 118:256-263. 10.1016/j.schres.2010.01.032, 20206475.
39. Sipos A, Harrison G, Gunnell D, Amin S, Singh SP. Patterns and predictors of hospitalization in first-episode psychosis. Br J Psychiatry 2001, 178:518-523. 10.1192/bjp.178.6.518, 11388967.
40. Martínez-Ortega JM, Gutiérrez-Rojas L, Jurado D, Higueras A, Diaz FJ, Gurpegui M. Factors associated with frequent psychiatric admissions in a general hospital in Spain. Int J Soc Psychiatry 2012, 58:532-535. 10.1177/0020764011413061, 21724657.